Everolimus Tablet — FDA Drug Shortage

To Be Discontinued — Mylan Pharmaceuticals Inc., a Viatris Company

The FDA lists a drug shortage record for Everolimus Tablet (tablet) from Mylan Pharmaceuticals Inc., a Viatris Company with status To Be Discontinued. The shortage was first posted on 11/03/2025.

Shortage Details

Status
To Be Discontinued
Company
Mylan Pharmaceuticals Inc., a Viatris Company
Package NDC
0378-0005-85
Dosage Form
Tablet
Presentation
Everolimus, Tablet, 2 mg (NDC 0378-0005-85)
Initial Posting
11/03/2025
Revised Date